SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Corbett KS, Edwards DK, Leist SR, Abiona OM, et al. Nature 2020 Aug 5. pii: 10.1038/s41586-020-2622.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Corbett KS, Edwards DK, Leist SR, Abiona OM, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 2020 Aug 5. pii: 10.1038/s41586-020-2622.
PMID: 32756549